Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARVARD BIOSCIENCE INCHBIO · Entity 7369 | Director | January 02, 2018 | January 04, 2018 |
| TECOGEN INC.TGEN · Entity 6846 | Director | June 26, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARVARD BIOSCIENCE INC
Report date January 02, 2018 · Filed January 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 477,050 |
Reported balance
After 2018-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-01-02 · Grant · Acquired 9,700 · Balance 477,050 F1: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares.
F2: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person.
TECOGEN INC.
Report date June 26, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.17 · Expires 2036-06-26 | Direct | 25,000 |
Reported balance
After 2026-06-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 25,000 · Balance 25,000 F1: Vests 25% per year |
Filing footnotes · ownership attribution and instrument terms
F1: Vests 25% per year
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FLIR SYSTEMS INC
Report date May 14, 2021 · Filed May 14, 2021
Section 16 reporting ended · disclosed 2021-05-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-05-14 · Disposition to issuer · Disposed 599,383 · Balance 68,308 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. Row 2 · 2021-05-14 · Disposition to issuer · Disposed 68,308 · Balance 0 F2: Pursuant to the Merger Agreement, each FLIR restricted stock unit, including performance-based restricted stock units that were earned but subject to service-based vesting ("FLIR RSU") outstanding immediately prior to the Effective Time automatically vested and was cancelled and converted into the right to receive $56.00 in cash in respect of each share of FLIR common stock subject to such FLIR RSU. |
| Common StockSEC Table I · non-derivative | IndirectChildren's Trust | 0 |
Reported balance
After 2021-05-14 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-05-14 · Disposition to issuer · Disposed 30,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 0 |
Reported balance
After 2021-05-14 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-05-14 · Disposition to issuer · Disposed 176,832 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes.
F2: Pursuant to the Merger Agreement, each FLIR restricted stock unit, including performance-based restricted stock units that were earned but subject to service-based vesting ("FLIR RSU") outstanding immediately prior to the Effective Time automatically vested and was cancelled and converted into the right to receive $56.00 in cash in respect of each share of FLIR common stock subject to such FLIR RSU.
NxStage Medical, Inc.
Report date February 21, 2019 · Filed February 25, 2019
Section 16 reporting ended · disclosed 2019-02-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 1
1 source rowRow 1 · 2019-02-21 · Disposition to issuer · Disposed 100,232 · Balance 0 F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.16 · Expires 2024-05-21 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-21 · Disposition to issuer · Disposed 23,394 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.81 · Expires 2025-05-20 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-21 · Disposition to issuer · Disposed 19,724 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.32 · Expires 2023-05-25 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-02-21 · Disposition to issuer · Disposed 15,854 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.78 · Expires 2024-05-24 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-21 · Disposition to issuer · Disposed 15,643 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2019 Filed Feb 25, 2019 20:56 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Disposition to issuerStock Option (Right to Buy) · Derivative | 19,724 | $0.00 Strike: $16.81 | $0.00 |
DisclosureSEC source: 0001246360-19-000743 · form.xml · derivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,724 shares Expires 2025-05-20 F2 · kind: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 20:56 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Disposition to issuerStock Option (Right to Buy) · Derivative | 23,394 | $0.00 Strike: $13.16 | $0.00 |
DisclosureSEC source: 0001246360-19-000743 · form.xml · derivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,394 shares Expires 2024-05-21 F2 · kind: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 20:56 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Disposition to issuerCommon Stock | 100,232 | $30.00 | $3,006,960.00 |
DisclosureSEC source: 0001246360-19-000743 · form.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 14:10 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 20,000 | $62.25 | $1,245,000.00 |
DisclosureSEC source: 0000354908-18-000079 · wf-form4_153573898726543.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,387 Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 14:40 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 15,000 | $59.99 | $899,850.00 |
DisclosureSEC source: 0000354908-18-000078 · wf-form4_153479043960184.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,387 Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 14:40 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 10,000 | $60.25 | $602,500.00 |
DisclosureSEC source: 0000354908-18-000078 · wf-form4_153479043960184.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,387 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 48,100 | $0.00 Strike: $25.64 | $0.00 |
DisclosureSEC source: 0000354908-18-000076 · wf-form4_153305434353691.xml · derivative · entry 8 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,100 shares Expires 2019-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 141,700 | $0.00 Strike: $25.64 | $0.00 |
DisclosureSEC source: 0000354908-18-000076 · wf-form4_153305434353691.xml · derivative · entry 7 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 141,700 shares Expires 2019-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Tax withholdingCommon Stock | 101,434 | $59.37 | $6,022,136.58 |
DisclosureSEC source: 0000354908-18-000076 · wf-form4_153305434353691.xml · nonDerivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,387 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 39,508 | $59.05 | $2,332,947.40 |
DisclosureSEC source: 0000354908-18-000076 · wf-form4_153305434353691.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,821 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionCommon Stock | 48,100 | $25.64 | $1,233,284.00 |
DisclosureSEC source: 0000354908-18-000076 · wf-form4_153305434353691.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionCommon Stock | 141,700 | $25.64 | $3,633,188.00 |
DisclosureSEC source: 0000354908-18-000076 · wf-form4_153305434353691.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| May 22, 2018 Filed May 24, 2018 16:18 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-18-000064 · wf-form4_152719311236090.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Children's Trust Disclosed balance after: 70,000 Read SEC document |
| April 27, 2018 Filed May 1, 2018 11:12 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GrantCommon Stock | 2,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-18-000044 · wf-form4_152518752031395.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,345 F1 · shares: This is a restricted stock grant expected to vest on 4/19/2019. F2 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 13:41 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 9,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001618 · doc4.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,050 F1 · shares: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person. Read SEC document |
| November 29, 2017 Filed Nov 29, 2017 18:08 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-17-000079 · wf-form4_151199686991742.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,485 Read SEC document |
| November 28, 2017 Filed Nov 29, 2017 22:28 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | GiftCommon Stock | 8,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-003161 · form.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,232 Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 17:20 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 129,500 | $0.00 Strike: $34.31 | $0.00 |
DisclosureSEC source: 0000354908-17-000071 · wf-form4_150948479272477.xml · derivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 129,500 shares Expires 2018-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 17:20 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 136,631 | $47.32 | $6,465,378.92 |
DisclosureSEC source: 0000354908-17-000071 · wf-form4_150948479272477.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,485 Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 17:20 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionCommon Stock | 129,500 | $34.31 | $4,443,145.00 |
DisclosureSEC source: 0000354908-17-000071 · wf-form4_150948479272477.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 15:31 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 20,000 | $38.22 | $764,400.00 |
DisclosureSEC source: 0000354908-17-000059 · wf-form4_150299828129835.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,379 Read SEC document |
| August 11, 2017 Filed Feb 2, 2018 16:20 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | OtherCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-18-000001 · wf-form5_151760642579911.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,181 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 12:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 11,587 | $37.27 | $431,847.49 |
DisclosureSEC source: 0000354908-17-000057 · wf-form4_150169120007431.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 529,379 F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 12:30 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Tax withholdingCommon Stock | 10,562 | $38.94 | $411,284.28 |
DisclosureSEC source: 0000354908-17-000041 · wf-form4_149668021735764.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,672 Read SEC document |
| May 25, 2017 Filed May 26, 2017 19:49 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | GrantStock Option (Right to Buy) · Derivative | 15,643 | $0.00 Strike: $22.78 | $0.00 |
DisclosureSEC source: 0001246360-17-002023 · form.xml · derivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,643 Underlying: Common Stock · 15,643 shares Expires 2024-05-24 F1 · derivative.exercise_date: The stock option becomes exercisable in 12 equal monthly installments beginning June 25, 2017. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:53 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 7,238 | $2.33 | $16,864.54 |
DisclosureSEC source: 0001209191-17-036313 · doc4.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,350 F4 · price: This transaction was executed in multiple trades at prices ranging from $2.31 to $2.34. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 426,600 shares of common stock held by the Reporting Person. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:53 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 5,000 | $2.38 | $11,900.00 |
DisclosureSEC source: 0001209191-17-036313 · doc4.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,112 F3 · balance_after: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 419,362 shares of common stock held by the Reporting Person. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:53 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 31,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036313 · doc4.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,112 F1 · shares: Represents a deferred stock award of 31,300 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018. F2 · balance_after: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 414,362 shares of common stock held by the Reporting Person. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:27 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 5,000 | $2.37 | $11,850.00 |
DisclosureSEC source: 0001209191-17-035372 · doc4.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,012 F3 · balance_after: Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 409,762 shares of common stock held by the Reporting Person. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:27 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 5,000 | $2.39 | $11,950.00 |
DisclosureSEC source: 0001209191-17-035372 · doc4.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,012 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.37 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 404,762 shares of common stock held by the Reporting Person. Read SEC document |
| May 18, 2017 Filed Jun 8, 2017 20:21 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 9,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-038536 · doc4.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,350 F1 · price: The subject restricted stock units were granted to the reporting person on January 3, 2017 and were forfeited as a result of the reporting person stepping down from his roles as Chairman of the Board of Directors, Chairman and Member of the Governance Committee, and Member of the Compensation Committee of the Issuer. F2 · balance_after: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 426,600 shares of common stock held by the Reporting Person. Read SEC document |
| May 12, 2017 Filed May 15, 2017 12:03 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 15,000 | $37.26 | $558,900.00 |
DisclosureSEC source: 0000354908-17-000033 · wf-form4_149486419575273.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,234 Read SEC document |
| April 28, 2017 Filed May 2, 2017 17:07 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 8,721 | $0.00 Strike: $36.73 | $0.00 |
DisclosureSEC source: 0000354908-17-000014 · wf-form4_149375925633479.xml · derivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,721 Underlying: Common Stock · 8,721 shares Expires 2027-04-28 Read SEC document |
| April 28, 2017 Filed May 2, 2017 17:07 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GrantCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-17-000014 · wf-form4_149375925633479.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,234 F1 · shares: This is a grant of restricted stock units expected to vest on 4/20/2018. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 12:28 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 250,000 | $0.00 Strike: $20.75 | $0.00 |
DisclosureSEC source: 0000354908-17-000006 · wf-form4_149020008515099.xml · derivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 12:28 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Tax withholdingCommon Stock | 188,413 | $36.77 | $6,927,946.01 |
DisclosureSEC source: 0000354908-17-000006 · wf-form4_149020008515099.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,158 Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 12:28 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionCommon Stock | 250,000 | $20.75 | $5,187,500.00 |
DisclosureSEC source: 0000354908-17-000006 · wf-form4_149020008515099.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 752,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:47 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 31,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001052 · doc4.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,012 F1 · shares: Represents a deferred stock award of 31,000 restricted stock units which vest quarterly in equal installments on March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2017. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 31,000 restricted stock units which vest quarterly in equal installments on March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017; (b) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; and (c) 366,712 shares of common stock held by the Reporting Person. Read SEC document |
| December 06, 2016 Filed Dec 7, 2016 22:00 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | SaleCommon Stock | 23,088 | $2.42 | $55,872.96 |
DisclosureSEC source: 0001209191-16-153928 · doc4.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,012 F1 · price: The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; (b) a deferred stock award of 6,350 restricted stock units which vests in full on December 31, 2016; and (c) 360,362 shares of common stock held by the Reporting Person. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 17:34 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GiftCommon Stock | 18,168 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-16-000174 · wf-form4_148097724582649.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,235 F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 13:26 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 52,000 | $32.40 | $1,684,800.00 |
DisclosureSEC source: 0000354908-16-000170 · wf-form4_147828039344031.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,130 F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 22:42 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,196 | $0.00 Strike: $13.60 | $0.00 |
DisclosureSEC source: 0001246360-16-007085 · form.xml · derivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,196 shares Expires 2018-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 22:42 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,272 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001246360-16-007085 · form.xml · derivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,272 shares Expires 2017-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 22:42 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 18,196 | $13.60 | $247,465.60 |
DisclosureSEC source: 0001246360-16-007085 · form.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 22:42 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 15,272 | $14.99 | $228,927.28 |
DisclosureSEC source: 0001246360-16-007085 · form.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.